title: Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.
authors.affiliation: University Hospital, Kuala Lumpur, Malaysia.
authors.forename: B L
authors.initials: BL
authors.lastname: Goh
authors.forename: R
authors.initials: R
authors.lastname: Jalil
authors.forename: S N
authors.initials: SN
authors.lastname: Koh
authors.forename: C T
authors.initials: CT
authors.lastname: Chua
authors.forename: S Y
authors.initials: SY
authors.lastname: Tan
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D005500:Follow-Up Studies; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008296:Malaysia; D008297:Male; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine